Nucleic acid synthesis as a drug target Flashcards
Roles of Nucleotides
Information storage (DNA,RNA) Energy Storage (ATP) Information Transfer (cAMP. GTP) Co-factors (NAD(H), NADP(H), FAD, CoA.)
Nucleobases
Pyrimidines (single ring) or purines (double ring)
Adenine, Thymine, Cytosine, Guanine
Nucleosides - adenosine, guanosine etc.
Parasitic Protozoa do not possess purine biosynthetic pathways
They scavenge purines from their host
Using specific purine transporter proteins.
Inter-conservation of purines using purine salvage enzymes
Multiple purine transporters in bloodstream Trypanosoma Brucei
Overlapping substrate selectivity.
Substrates of T.brucei P2 adenosine transporter include:
Adenosine, adenine (purines), pentamidine, melarsoprol, isometamidium (trypanocides).
Nucleotide biosynthesis
Nucleosides converted to nucleobases by nucleoside phosphorylase.
Nucleobases converted to nucleotides by phosphoribosyl transferases.
Allopurinol
Used in the treatment of gout.
It is a hypoxanthine analogue and it inhibits xanthine oxidase, stopping hypoxanthine being cpnverted into uric acid.
It is also a substrate of hypoxanthine phosphoribosyl transferase in trypanosomatids and has been used clinically in the treatment of leishmaniasis.
Differences between protozoa
Adenosine is the primary precursor of all purine nucleotides in Trichonmonas vaginalis.
in this case there is no role for hypoxanthine as there is no phosphoribosyl transferases.
Polyamines
Essential for DNA and RNA stability and replication.
polyamines are cellular cations present in high abundance.
They bind many cellular anions i.e DNA and RNA and stabilise them by neutralising the negative charge.
They appear to be crucial to proliferating cells, and therefore polyamide metabolism is a good drug target in rapidly proliferating prtotozoa such as trypanosomes.
Trypanothione
the Trypanosomatids the roles of glutathione are taken on by trypanothione molecules.
It comprises of 2 glutathione moieties linked by a spermidine moiety.
In many cells glutathione is a key low molecular weight thiol that is involved in maintaining the intracellular redox environment.
Trypanothione is synthesised from the reduction of trypanothione disuphide + spermidine by trypanothione reductase.
Trypanosomes treated with Eflornithine
In the trypanosome-
Ornithine levels increase.
Putrescine, spermidine and trypanothione levels fall.
De-carboxylated s-adenosylmethionine levels increase.
Ornithine decarboxylase is the target for Eflornithine.
Sulphonamides (sulfa)
Prontosil dye - effective against streptococci.
First group of chemical substances systematically used to treat and prevent bacterial infections in humans.
The folate pathway
S-adenosylmethionine is one key methyl donor in the cell, another is folate (or its derivatives).
The folate pathway has been shown to be important in a number of protozoa, particularly apicomplexans like plasmodium and toxoplasma.
Mammals obtain folate from green veggies (folliage).
Apicomplexan parasites make their own folate from GTP.
Folate is an essential co-factor, structurally related to purines.
Folates in Plasmodium
Folates are synthesised from GTP and PABA, they are essential for nucleotide metabolism.
Dihydropteroate synthase - can be inihibited by PABA analogues such as sulphonamides.
Dihydrofolate reductase - can be inhibited by folate analogues such as pyrimethimine and cycloguanil.
Fansidar (sulphadoxine-pyrimethamine)
Introduced in 1960s as a synergistic anti-malarial drug
Reports of resistance within a few years.
Used as a second-line drug in areas where Chloroquine is still used.
In areas that are Choroquine resistant, it is a first line anti-malarial.
Many hyperendemic and holoendemic areas that are now Fansidar resistant.
Artemisinins are taking over as first line drug in many places.
Mechanism of Fansidar resistance
Many theories, potentially many causes -
Amplification/overexpression of the DHFR-TS gene
Modification of transport of various substrates involved in folate biosynthesis.
Drug efflux
P.Vidax inherant resistance to anti-folates due to conformation of active site cavity of PvDHFR-TS.
Point mutations resulting in the substitution of amino acid residues that form the active site of DHFR-TS enzyme, leading to decreased affinity between enzyme and anti-folates.